
Protagonist Therapeutics (PTGX) Market Capitalization Overview
Market Cap: $3.35B as of Jun 18, 2025
$3.35B
Past Month+$517.55M (18.32%)
As of Jun 18, 2025, Protagonist Therapeutics (PTGX) has a market capitalization of $3.35B. Over the past 30 days, its market cap has increased by 12.55%, while in the last 12 months, it has increased by 45.28%.
Market capitalization represents the total value of Protagonist Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Protagonist Therapeutics (PTGX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Protagonist Therapeutics (PTGX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Protagonist Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Protagonist Therapeutics (PTGX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Protagonist Therapeutics (PTGX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Protagonist Therapeutics (PTGX) Market Cap & Key Trends
See Protagonist Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Protagonist Therapeutics (PTGX)
Order type
Buy in
Order amount
Est. shares
0 shares
Protagonist Therapeutics (PTGX) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $3.11B | +12.55% |
May 1, 2025 | $2.77B | -4.03% |
Apr 1, 2025 | $2.88B | +21.77% |
Mar 3, 2025 | $2.37B | +6.60% |
Feb 3, 2025 | $2.22B | -4.57% |
Jan 2, 2025 | $2.33B | -9.89% |
Protagonist Therapeutics (PTGX) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $3.35B | +45.28% |
2024 | $2.31B | +73.94% |
2023 | $1.33B | +146.40% |
2022 | $536.76M | -67.12% |
2021 | $1.64B | +92.43% |
2020 | $848.27M | — |
FAQs About Protagonist Therapeutics (PTGX) Market Cap
As of Jun 18, 2025, the market capitalization of Protagonist Therapeutics (PTGX) is $3.35B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Protagonist Therapeutics’s market capitalization has increased by 18.32%, changing from $2.83B to $3.35B as of Jun 18, 2025.
In the last 3 months, Protagonist Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Protagonist Therapeutics’s market capitalization increased from $1.33B in January to $2.31B in December, reflecting a 73.94% change.
In the past five years, Protagonist Therapeutics (PTGX) has had a compound annual growth rate (CAGR) of 22.08% in market capitalization. This means its market cap has grown at an average rate of 22.08% per year.